Condition: Heart Transplantation · Rejection Heart Transplant · HLA Antigens · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
The goal of this observational study is to systematically assess the presence and distribution of CMR-defined inflammation and fibrosis in clinically stable HT recipients with DSA detected during active screening for AMR surveillance. The main outcome is to study the prevalence of fibrosis, edema and of altered T1 mapping values in patients with DSA and the prevalence of patients with DSA among all the enrolled patients
This description comes directly from the study's public registry record.
Luciano Potena, MD · 0512143725 · scompenso.trapiantocuore@aosp.bo.it
Always discuss trial participation with your own doctor first.
| Azienda Ospedaliera Universitaria Consorziale Policlinico di Bari | Bari, Bari, Italy | Not Yet Recruiting |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | Bologna, Bologna, Italy | Recruiting |
| ASST Grande Ospedale Metropolitano Niguarda | Milan, Milano, Italy | Recruiting |
| Azienda Ospedaliera dei Colli | Naples, Napoli, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06774365